BIOMAT Database Logo BIOMAT Database Logo

Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. 2013

Dwarakanathan Ranganathan, and Robert Fassett, and George T John

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014395 Peritonitis, Tuberculous A form of PERITONITIS seen in patients with TUBERCULOSIS, characterized by lesion either as a miliary form or as a pelvic mass on the peritoneal surfaces. Most patients have ASCITES, abdominal swelling, ABDOMINAL PAIN, and other systemic symptoms such as FEVER; WEIGHT LOSS; and ANEMIA. Tuberculosis, Peritoneal
D017291 Clarithromycin A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. 6-O-Methylerythromycin,A-56268,Biaxin,TE-031,A 56268,A56268,TE 031,TE031

Related Publications

Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis.
January 1999, American journal of nephrology,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis.
January 1992, Scandinavian journal of infectious diseases,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
April 1986, Journal of clinical microbiology,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
January 1993, The Korean journal of internal medicine,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium fortuitum Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis (CAPD): A Case Report.
December 2013, Journal of clinical and diagnostic research : JCDR,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium fortuitum infection in continuous ambulatory peritoneal dialysis.
December 2008, Clinical nephrology,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Penicillium peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.
January 1998, Heart & lung : the journal of critical care,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Penicillium peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.
June 1996, Diagnostic microbiology and infectious disease,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Mycobacterium mucogenicum peritonitis in a continuous ambulatory peritoneal dialysis patient.
January 2012, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Dwarakanathan Ranganathan, and Robert Fassett, and George T John
Acinetobacter lwoffii peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.
February 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Copied contents to your clipboard!